(In the Media) “Clinical Trials Using Cancer Treatment for Terminal Nerve Disease「Doctor Led Clinical Trials」Complex Processes Hinder Establishment” (Sankei Shimbun, November 5, 2014) (in Japanese)
date : 11/5/2014
An interview with HGPI’s Executive Director, Toshio Miyata, was featured in the following article:
“Clinical Trials Using Cancer Treatment for Terminal Nerve Disease「Doctor Led Clinical Trials」Complex Processes Hinder Establishment”
(Sankei Shimbun, November 5, 2014) (in Japanese)
「神経の難病に抗がん剤治験「医師主導治験」手続き煩雑で定着せず」
“Clinical Trials Using Cancer Treatment for Terminal Nerve Disease「Doctor Led Clinical Trials」Complex Processes Hinder Establishment”
(Sankei Shimbun, November 5, 2014) (in Japanese)
「神経の難病に抗がん剤治験「医師主導治験」手続き煩雑で定着せず」
Top Research & Recommendations Posts
Featured Posts
-
2026-08-28
[Announcement] The 3rd Kiyoshi Kurokawa Award: Call for Nominations (Deadline: November 30, 2026)
-
2026-11-05
[Registration Open] HGPI Salon 2025-2026 Looking Ahead to the Future of Japan’s Social Security System “Session 7: Where We’ve Been and Where We’re Going: Lessons from Pandemic Response” (December 18, 2026)
-
2026-11-13
[Discussion Points] Addressing AMR Measures for an Era of Healthy Longevity: Ensuring Safety and Security for Older Adults in a Super-Aged Society (October 23, 2026)



